Paclitaxel Market in China - Manufacturing and Consumption, Outlook and Forecast 2020-2026
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it 'taxol'.
This report contains market size and forecasts of Paclitaxel in China, including the following market information:
China Paclitaxel Market Revenue, 2015-2020, 2021-2026, ($ millions)
China Paclitaxel Market Consumption, 2015-2020, 2021-2026, (Kg)
China Paclitaxel Production Capacity, 2015-2020, 2021-2026, (Kg)
Top Five Competitors in China Paclitaxel Market 2019 (%)
The global Paclitaxel market was valued at 110.4 million in 2019 and is projected to reach US$ 152 million by 2026, at a CAGR of 8.3% during the forecast period. While the Paclitaxel market size in China was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Paclitaxel manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Paclitaxel production and consumption in China
Total Market by Segment:
China Paclitaxel Market, By Type, 2015-2020, 2021-2026 ($ millions) & (Kg)
China Paclitaxel Market Segment Percentages, By Type, 2019 (%)
China Paclitaxel Market Segment Percentages, By Application, 2019 (%)
The report also provides analysis of leading market participants including:
Total Paclitaxel Market Competitors Revenues in China, by Players 2015-2020 (Estimated), ($ millions)
Total Paclitaxel Market Competitors Revenues Share in China, by Players 2019 (%)
Total China Paclitaxel Market Competitors Sales, by Players 2015-2020 (Estimated), (Kg)
Total China Paclitaxel Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
This report contains market size and forecasts of Paclitaxel in China, including the following market information:
China Paclitaxel Market Revenue, 2015-2020, 2021-2026, ($ millions)
China Paclitaxel Market Consumption, 2015-2020, 2021-2026, (Kg)
China Paclitaxel Production Capacity, 2015-2020, 2021-2026, (Kg)
Top Five Competitors in China Paclitaxel Market 2019 (%)
The global Paclitaxel market was valued at 110.4 million in 2019 and is projected to reach US$ 152 million by 2026, at a CAGR of 8.3% during the forecast period. While the Paclitaxel market size in China was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Paclitaxel manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Paclitaxel production and consumption in China
Total Market by Segment:
China Paclitaxel Market, By Type, 2015-2020, 2021-2026 ($ millions) & (Kg)
China Paclitaxel Market Segment Percentages, By Type, 2019 (%)
- Natural Paclitaxel API
- Semi-synthetic Paclitaxel API
China Paclitaxel Market Segment Percentages, By Application, 2019 (%)
- Ovarian Cancer
- Cervical Cancer
- Breast Cancer
- Other
The report also provides analysis of leading market participants including:
Total Paclitaxel Market Competitors Revenues in China, by Players 2015-2020 (Estimated), ($ millions)
Total Paclitaxel Market Competitors Revenues Share in China, by Players 2019 (%)
Total China Paclitaxel Market Competitors Sales, by Players 2015-2020 (Estimated), (Kg)
Total China Paclitaxel Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
- Phyton
- ScinoPharm
- Novasep
- Samyang
- Polymed
- TAPI (Teva)
- Fresenius-kabi
- Huiang biopharma
- Southpharma
- Yunnan Hande
- Hainan Yew Pharm
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Paclitaxel Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Paclitaxel Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: CHINA PACLITAXEL OVERALL MARKET SIZE
2.1 China Paclitaxel Market Size: 2020 VS 2026
2.2 China Paclitaxel Revenue, Prospects & Forecasts: 2015-2026
2.3 China Paclitaxel Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Paclitaxel Players in China (including Foreign and Local Companies)
3.2 Top China Paclitaxel Companies Ranked by Revenue
3.3 China Paclitaxel Revenue by Companies (including Foreign and Local Companies)
3.4 China Paclitaxel Sales by Companies (including Foreign and Local Companies)
3.5 China Paclitaxel Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Paclitaxel Companies in China, by Revenue in 2019
3.7 China Manufacturers Paclitaxel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Paclitaxel Players in China
3.8.1 List of China Tier 1 Paclitaxel Companies
3.8.2 List of China Tier 2 and Tier 3 Paclitaxel Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - China Paclitaxel Market Size Markets, 2020 & 2026
4.1.2 Natural Paclitaxel API
4.1.3 Semi-synthetic Paclitaxel API
4.2 By Type - China Paclitaxel Revenue & Forecasts
4.2.1 By Type - China Paclitaxel Revenue, 2015-2020
4.2.2 By Type - China Paclitaxel Revenue, 2021-2026
4.2.3 By Type - China Paclitaxel Revenue Market Share, 2015-2026
4.3 By Type - China Paclitaxel Sales & Forecasts
4.3.1 By Type - China Paclitaxel Sales, 2015-2020
4.3.2 By Type - China Paclitaxel Sales, 2021-2026
4.3.3 By Type - China Paclitaxel Sales Market Share, 2015-2026
4.4 By Type - China Paclitaxel Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - China Paclitaxel Market Size, 2020 & 2026
5.1.2 Ovarian Cancer
5.1.3 Cervical Cancer
5.1.4 Breast Cancer
5.1.5 Other
5.2 By Application - China Paclitaxel Revenue & Forecasts
5.2.1 By Application - China Paclitaxel Revenue, 2015-2020
5.2.2 By Application - China Paclitaxel Revenue, 2021-2026
5.2.3 By Application - China Paclitaxel Revenue Market Share, 2015-2026
5.3 By Application - China Paclitaxel Sales & Forecasts
5.3.1 By Application - China Paclitaxel Sales, 2015-2020
5.3.2 By Application - China Paclitaxel Sales, 2021-2026
5.3.3 By Application - China Paclitaxel Sales Market Share, 2015-2026
5.4 By Application - China Paclitaxel Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 Phyton
6.1.1 Phyton Corporate Summary
6.1.2 Phyton Business Overview
6.1.3 Phyton Paclitaxel Major Product Offerings
6.1.4 Phyton Sales and Revenue in China (2015-2020)
6.1.5 Phyton Key News
6.2 ScinoPharm
6.2.1 ScinoPharm Corporate Summary
6.2.2 ScinoPharm Business Overview
6.2.3 ScinoPharm Paclitaxel Major Product Offerings
6.2.4 ScinoPharm Sales and Revenue in China (2015-2020)
6.2.5 ScinoPharm Key News
6.3 Novasep
6.3.1 Novasep Corporate Summary
6.3.2 Novasep Business Overview
6.3.3 Novasep Paclitaxel Major Product Offerings
6.3.4 Novasep Sales and Revenue in China (2015-2020)
6.3.5 Novasep Key News
6.4 Samyang
6.4.1 Samyang Corporate Summary
6.4.2 Samyang Business Overview
6.4.3 Samyang Paclitaxel Major Product Offerings
6.4.4 Samyang Sales and Revenue in China (2015-2020)
6.4.5 Samyang Key News
6.5 Polymed
6.5.1 Polymed Corporate Summary
6.5.2 Polymed Business Overview
6.5.3 Polymed Paclitaxel Major Product Offerings
6.5.4 Polymed Sales and Revenue in China (2015-2020)
6.5.5 Polymed Key News
6.6 TAPI (Teva)
6.6.1 TAPI (Teva) Corporate Summary
6.6.2 TAPI (Teva) Business Overview
6.6.3 TAPI (Teva) Paclitaxel Major Product Offerings
6.6.4 TAPI (Teva) Sales and Revenue in China (2015-2020)
6.6.5 TAPI (Teva) Key News
6.7 Fresenius-kabi
6.6.1 Fresenius-kabi Corporate Summary
6.6.2 Fresenius-kabi Business Overview
6.6.3 Fresenius-kabi Paclitaxel Major Product Offerings
6.4.4 Fresenius-kabi Sales and Revenue in China (2015-2020)
6.7.5 Fresenius-kabi Key News
6.8 Huiang biopharma
6.8.1 Huiang biopharma Corporate Summary
6.8.2 Huiang biopharma Business Overview
6.8.3 Huiang biopharma Paclitaxel Major Product Offerings
6.8.4 Huiang biopharma Sales and Revenue in China (2015-2020)
6.8.5 Huiang biopharma Key News
6.9 Southpharma
6.9.1 Southpharma Corporate Summary
6.9.2 Southpharma Business Overview
6.9.3 Southpharma Paclitaxel Major Product Offerings
6.9.4 Southpharma Sales and Revenue in China (2015-2020)
6.9.5 Southpharma Key News
6.10 Yunnan Hande
6.10.1 Yunnan Hande Corporate Summary
6.10.2 Yunnan Hande Business Overview
6.10.3 Yunnan Hande Paclitaxel Major Product Offerings
6.10.4 Yunnan Hande Sales and Revenue in China (2015-2020)
6.10.5 Yunnan Hande Key News
6.11 Hainan Yew Pharm
6.11.1 Hainan Yew Pharm Corporate Summary
6.11.2 Hainan Yew Pharm Paclitaxel Business Overview
6.11.3 Hainan Yew Pharm Paclitaxel Major Product Offerings
6.11.4 Hainan Yew Pharm Sales and Revenue in China (2015-2020)
6.11.5 Hainan Yew Pharm Key News
6.12 Jiangsu Yew Biotechnology
6.12.1 Jiangsu Yew Biotechnology Corporate Summary
6.12.2 Jiangsu Yew Biotechnology Paclitaxel Business Overview
6.12.3 Jiangsu Yew Biotechnology Paclitaxel Major Product Offerings
6.12.4 Jiangsu Yew Biotechnology Sales and Revenue in China (2015-2020)
6.12.5 Jiangsu Yew Biotechnology Key News
7 PACLITAXEL PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Paclitaxel Production Capacity and Value in China, Situation Analysis and Prediction, 2015-2026
7.1.1 China Paclitaxel Production Capacity, 2015-2026
7.1.2 China Paclitaxel Production 2015-2026
7.1.3 China Paclitaxel Production Value 2015-2026
7.2 Key Local Paclitaxel Manufacturers in China
7.2.1 China Key Local Paclitaxel Manufacturers Production Capacity
7.2.2 China Key Local Paclitaxel Manufacturers Production
7.2.3 China Key Local Paclitaxel Manufacturers Production Value
7.2.4 The Proportion of Paclitaxel Production Sold in China and Sold Other Than China by Manufacturers
7.3 Paclitaxel Export and Import in China
7.3.1 China Paclitaxel Export Market
7.3.2 China Paclitaxel Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for China Paclitaxel Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON PACLITAXEL SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Paclitaxel Distributors and Sales Agents in China
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
1.1 Paclitaxel Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Paclitaxel Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: CHINA PACLITAXEL OVERALL MARKET SIZE
2.1 China Paclitaxel Market Size: 2020 VS 2026
2.2 China Paclitaxel Revenue, Prospects & Forecasts: 2015-2026
2.3 China Paclitaxel Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Paclitaxel Players in China (including Foreign and Local Companies)
3.2 Top China Paclitaxel Companies Ranked by Revenue
3.3 China Paclitaxel Revenue by Companies (including Foreign and Local Companies)
3.4 China Paclitaxel Sales by Companies (including Foreign and Local Companies)
3.5 China Paclitaxel Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Paclitaxel Companies in China, by Revenue in 2019
3.7 China Manufacturers Paclitaxel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Paclitaxel Players in China
3.8.1 List of China Tier 1 Paclitaxel Companies
3.8.2 List of China Tier 2 and Tier 3 Paclitaxel Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - China Paclitaxel Market Size Markets, 2020 & 2026
4.1.2 Natural Paclitaxel API
4.1.3 Semi-synthetic Paclitaxel API
4.2 By Type - China Paclitaxel Revenue & Forecasts
4.2.1 By Type - China Paclitaxel Revenue, 2015-2020
4.2.2 By Type - China Paclitaxel Revenue, 2021-2026
4.2.3 By Type - China Paclitaxel Revenue Market Share, 2015-2026
4.3 By Type - China Paclitaxel Sales & Forecasts
4.3.1 By Type - China Paclitaxel Sales, 2015-2020
4.3.2 By Type - China Paclitaxel Sales, 2021-2026
4.3.3 By Type - China Paclitaxel Sales Market Share, 2015-2026
4.4 By Type - China Paclitaxel Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - China Paclitaxel Market Size, 2020 & 2026
5.1.2 Ovarian Cancer
5.1.3 Cervical Cancer
5.1.4 Breast Cancer
5.1.5 Other
5.2 By Application - China Paclitaxel Revenue & Forecasts
5.2.1 By Application - China Paclitaxel Revenue, 2015-2020
5.2.2 By Application - China Paclitaxel Revenue, 2021-2026
5.2.3 By Application - China Paclitaxel Revenue Market Share, 2015-2026
5.3 By Application - China Paclitaxel Sales & Forecasts
5.3.1 By Application - China Paclitaxel Sales, 2015-2020
5.3.2 By Application - China Paclitaxel Sales, 2021-2026
5.3.3 By Application - China Paclitaxel Sales Market Share, 2015-2026
5.4 By Application - China Paclitaxel Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 Phyton
6.1.1 Phyton Corporate Summary
6.1.2 Phyton Business Overview
6.1.3 Phyton Paclitaxel Major Product Offerings
6.1.4 Phyton Sales and Revenue in China (2015-2020)
6.1.5 Phyton Key News
6.2 ScinoPharm
6.2.1 ScinoPharm Corporate Summary
6.2.2 ScinoPharm Business Overview
6.2.3 ScinoPharm Paclitaxel Major Product Offerings
6.2.4 ScinoPharm Sales and Revenue in China (2015-2020)
6.2.5 ScinoPharm Key News
6.3 Novasep
6.3.1 Novasep Corporate Summary
6.3.2 Novasep Business Overview
6.3.3 Novasep Paclitaxel Major Product Offerings
6.3.4 Novasep Sales and Revenue in China (2015-2020)
6.3.5 Novasep Key News
6.4 Samyang
6.4.1 Samyang Corporate Summary
6.4.2 Samyang Business Overview
6.4.3 Samyang Paclitaxel Major Product Offerings
6.4.4 Samyang Sales and Revenue in China (2015-2020)
6.4.5 Samyang Key News
6.5 Polymed
6.5.1 Polymed Corporate Summary
6.5.2 Polymed Business Overview
6.5.3 Polymed Paclitaxel Major Product Offerings
6.5.4 Polymed Sales and Revenue in China (2015-2020)
6.5.5 Polymed Key News
6.6 TAPI (Teva)
6.6.1 TAPI (Teva) Corporate Summary
6.6.2 TAPI (Teva) Business Overview
6.6.3 TAPI (Teva) Paclitaxel Major Product Offerings
6.6.4 TAPI (Teva) Sales and Revenue in China (2015-2020)
6.6.5 TAPI (Teva) Key News
6.7 Fresenius-kabi
6.6.1 Fresenius-kabi Corporate Summary
6.6.2 Fresenius-kabi Business Overview
6.6.3 Fresenius-kabi Paclitaxel Major Product Offerings
6.4.4 Fresenius-kabi Sales and Revenue in China (2015-2020)
6.7.5 Fresenius-kabi Key News
6.8 Huiang biopharma
6.8.1 Huiang biopharma Corporate Summary
6.8.2 Huiang biopharma Business Overview
6.8.3 Huiang biopharma Paclitaxel Major Product Offerings
6.8.4 Huiang biopharma Sales and Revenue in China (2015-2020)
6.8.5 Huiang biopharma Key News
6.9 Southpharma
6.9.1 Southpharma Corporate Summary
6.9.2 Southpharma Business Overview
6.9.3 Southpharma Paclitaxel Major Product Offerings
6.9.4 Southpharma Sales and Revenue in China (2015-2020)
6.9.5 Southpharma Key News
6.10 Yunnan Hande
6.10.1 Yunnan Hande Corporate Summary
6.10.2 Yunnan Hande Business Overview
6.10.3 Yunnan Hande Paclitaxel Major Product Offerings
6.10.4 Yunnan Hande Sales and Revenue in China (2015-2020)
6.10.5 Yunnan Hande Key News
6.11 Hainan Yew Pharm
6.11.1 Hainan Yew Pharm Corporate Summary
6.11.2 Hainan Yew Pharm Paclitaxel Business Overview
6.11.3 Hainan Yew Pharm Paclitaxel Major Product Offerings
6.11.4 Hainan Yew Pharm Sales and Revenue in China (2015-2020)
6.11.5 Hainan Yew Pharm Key News
6.12 Jiangsu Yew Biotechnology
6.12.1 Jiangsu Yew Biotechnology Corporate Summary
6.12.2 Jiangsu Yew Biotechnology Paclitaxel Business Overview
6.12.3 Jiangsu Yew Biotechnology Paclitaxel Major Product Offerings
6.12.4 Jiangsu Yew Biotechnology Sales and Revenue in China (2015-2020)
6.12.5 Jiangsu Yew Biotechnology Key News
7 PACLITAXEL PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Paclitaxel Production Capacity and Value in China, Situation Analysis and Prediction, 2015-2026
7.1.1 China Paclitaxel Production Capacity, 2015-2026
7.1.2 China Paclitaxel Production 2015-2026
7.1.3 China Paclitaxel Production Value 2015-2026
7.2 Key Local Paclitaxel Manufacturers in China
7.2.1 China Key Local Paclitaxel Manufacturers Production Capacity
7.2.2 China Key Local Paclitaxel Manufacturers Production
7.2.3 China Key Local Paclitaxel Manufacturers Production Value
7.2.4 The Proportion of Paclitaxel Production Sold in China and Sold Other Than China by Manufacturers
7.3 Paclitaxel Export and Import in China
7.3.1 China Paclitaxel Export Market
7.3.2 China Paclitaxel Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for China Paclitaxel Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON PACLITAXEL SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Paclitaxel Distributors and Sales Agents in China
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Paclitaxel in China
Table 2. Top Players in China, Ranking by Revenue (2019)
Table 3. China Paclitaxel Revenue by Companies, (US$, Mn), 2015-2020
Table 4. China Paclitaxel Revenue Share by Companies, 2015-2020
Table 5. China Paclitaxel Sales by Companies, (Kg), 2015-2020
Table 6. China Paclitaxel Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Paclitaxel Price (2015-2020) (USD/Kg)
Table 8. China Manufacturers Paclitaxel Product Type
Table 9. List of China Tier 1 Paclitaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of China Tier 2 and Tier 3 Paclitaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Paclitaxel Revenue in China (US$, Mn), 2015-2020
Table 12. By Type - Paclitaxel Revenue in China (US$, Mn), 2021-2026
Table 13. By Type - Paclitaxel Sales in China (Kg), 2015-2020
Table 14. By Type - Paclitaxel Sales in China (Kg), 2021-2026
Table 15. By Application - Paclitaxel Revenue in China, (US$, Mn), 2015-2020
Table 16. By Application - Paclitaxel Revenue in China, (US$, Mn), 2021-2026
Table 17. By Application - Paclitaxel Sales in China, (Kg), 2015-2020
Table 18. By Application - Paclitaxel Sales in China, (Kg), 2021-2026
Table 19. Phyton Corporate Summary
Table 20. Phyton Paclitaxel Product Offerings
Table 21. Phyton Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 22. ScinoPharm Corporate Summary
Table 23. ScinoPharm Paclitaxel Product Offerings
Table 24. ScinoPharm Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 25. Novasep Corporate Summary
Table 26. Novasep Paclitaxel Product Offerings
Table 27. Novasep Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 28. Samyang Corporate Summary
Table 29. Samyang Paclitaxel Product Offerings
Table 30. Samyang Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 31. Polymed Corporate Summary
Table 32. Polymed Paclitaxel Product Offerings
Table 33. Polymed Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 34. TAPI (Teva) Corporate Summary
Table 35. TAPI (Teva) Paclitaxel Product Offerings
Table 36. TAPI (Teva) Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 37. Fresenius-kabi Corporate Summary
Table 38. Fresenius-kabi Paclitaxel Product Offerings
Table 39. Fresenius-kabi Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 40. Huiang biopharma Corporate Summary
Table 41. Huiang biopharma Paclitaxel Product Offerings
Table 42. Huiang biopharma Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 43. Southpharma Corporate Summary
Table 44. Southpharma Paclitaxel Product Offerings
Table 45. Southpharma Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 46. Yunnan Hande Corporate Summary
Table 47. Yunnan Hande Paclitaxel Product Offerings
Table 48. Yunnan Hande Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 49. Hainan Yew Pharm Corporate Summary
Table 50. Hainan Yew Pharm Paclitaxel Product Offerings
Table 51. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 52. Jiangsu Yew Biotechnology Corporate Summary
Table 53. Jiangsu Yew Biotechnology Paclitaxel Product Offerings
Table 54. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 55. Paclitaxel Production Capacity (Kg) of Local Manufacturers in China, 2015-2020
Table 56. Paclitaxel Production (Kg) of Local Manufacturers in China, 2015-2020
Table 57. China Paclitaxel Production Market Share of Local Manufacturers, 2015-2020
Table 58. Paclitaxel Production Value (US$, Mn) of Local Manufacturers in China, 2015-2020
Table 59. China Paclitaxel Production Value Market Share of Local Manufacturers, 2015-2020
Table 60. The Percentage of Paclitaxel Production Sold in China and Sold Other Than China by Manufacturers
Table 61. The Percentage of Paclitaxel Production Sold in China and Sold Other Than China by Manufacturers
Table 62. Dangeguojia Paclitaxel Sales (Consumption), Production, Export and Import, 2015-2020
Table 63. Raw Materials and Suppliers
Table 64. Paclitaxel Downstream Clients in China
Table 65. Paclitaxel Distributors and Sales Agents in China
Table 1. Key Players of Paclitaxel in China
Table 2. Top Players in China, Ranking by Revenue (2019)
Table 3. China Paclitaxel Revenue by Companies, (US$, Mn), 2015-2020
Table 4. China Paclitaxel Revenue Share by Companies, 2015-2020
Table 5. China Paclitaxel Sales by Companies, (Kg), 2015-2020
Table 6. China Paclitaxel Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Paclitaxel Price (2015-2020) (USD/Kg)
Table 8. China Manufacturers Paclitaxel Product Type
Table 9. List of China Tier 1 Paclitaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of China Tier 2 and Tier 3 Paclitaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Paclitaxel Revenue in China (US$, Mn), 2015-2020
Table 12. By Type - Paclitaxel Revenue in China (US$, Mn), 2021-2026
Table 13. By Type - Paclitaxel Sales in China (Kg), 2015-2020
Table 14. By Type - Paclitaxel Sales in China (Kg), 2021-2026
Table 15. By Application - Paclitaxel Revenue in China, (US$, Mn), 2015-2020
Table 16. By Application - Paclitaxel Revenue in China, (US$, Mn), 2021-2026
Table 17. By Application - Paclitaxel Sales in China, (Kg), 2015-2020
Table 18. By Application - Paclitaxel Sales in China, (Kg), 2021-2026
Table 19. Phyton Corporate Summary
Table 20. Phyton Paclitaxel Product Offerings
Table 21. Phyton Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 22. ScinoPharm Corporate Summary
Table 23. ScinoPharm Paclitaxel Product Offerings
Table 24. ScinoPharm Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 25. Novasep Corporate Summary
Table 26. Novasep Paclitaxel Product Offerings
Table 27. Novasep Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 28. Samyang Corporate Summary
Table 29. Samyang Paclitaxel Product Offerings
Table 30. Samyang Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 31. Polymed Corporate Summary
Table 32. Polymed Paclitaxel Product Offerings
Table 33. Polymed Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 34. TAPI (Teva) Corporate Summary
Table 35. TAPI (Teva) Paclitaxel Product Offerings
Table 36. TAPI (Teva) Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 37. Fresenius-kabi Corporate Summary
Table 38. Fresenius-kabi Paclitaxel Product Offerings
Table 39. Fresenius-kabi Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 40. Huiang biopharma Corporate Summary
Table 41. Huiang biopharma Paclitaxel Product Offerings
Table 42. Huiang biopharma Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 43. Southpharma Corporate Summary
Table 44. Southpharma Paclitaxel Product Offerings
Table 45. Southpharma Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 46. Yunnan Hande Corporate Summary
Table 47. Yunnan Hande Paclitaxel Product Offerings
Table 48. Yunnan Hande Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 49. Hainan Yew Pharm Corporate Summary
Table 50. Hainan Yew Pharm Paclitaxel Product Offerings
Table 51. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 52. Jiangsu Yew Biotechnology Corporate Summary
Table 53. Jiangsu Yew Biotechnology Paclitaxel Product Offerings
Table 54. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 55. Paclitaxel Production Capacity (Kg) of Local Manufacturers in China, 2015-2020
Table 56. Paclitaxel Production (Kg) of Local Manufacturers in China, 2015-2020
Table 57. China Paclitaxel Production Market Share of Local Manufacturers, 2015-2020
Table 58. Paclitaxel Production Value (US$, Mn) of Local Manufacturers in China, 2015-2020
Table 59. China Paclitaxel Production Value Market Share of Local Manufacturers, 2015-2020
Table 60. The Percentage of Paclitaxel Production Sold in China and Sold Other Than China by Manufacturers
Table 61. The Percentage of Paclitaxel Production Sold in China and Sold Other Than China by Manufacturers
Table 62. Dangeguojia Paclitaxel Sales (Consumption), Production, Export and Import, 2015-2020
Table 63. Raw Materials and Suppliers
Table 64. Paclitaxel Downstream Clients in China
Table 65. Paclitaxel Distributors and Sales Agents in China
LIST OF FIGURES
Figure 1. Paclitaxel Segment by Type
Figure 2. Paclitaxel Segment by Application
Figure 3. Dangeguojia Paclitaxel Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Paclitaxel Market Size in China, (US$, Mn) & (Kg): 2020 VS 2026
Figure 6. China Paclitaxel Revenue, 2015-2026 (US$, Mn)
Figure 7. Paclitaxel Sales in China: 2015-2026 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Paclitaxel Revenue in 2019
Figure 9. By Type - China Paclitaxel Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - China Paclitaxel Market Share, 2015-2020
Figure 11. By Type - China Paclitaxel Market Share, 2020-2026
Figure 12. By Type - China Paclitaxel Price (USD/Kg), 2015-2026
Figure 13. By Application - Paclitaxel Revenue in China (US$, Mn), 2020 & 2026
Figure 14. By Application - China Paclitaxel Market Share, 2015-2020
Figure 15. By Application - China Paclitaxel Market Share, 2020-2026
Figure 16. By Application -China Paclitaxel Price (USD/Kg), 2015-2026
Figure 17. China Paclitaxel Production Capacity (Kg), 2015-2026
Figure 18. China Paclitaxel Actual Output (Kg), 2015-2026
Figure 19. China Paclitaxel Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of China Paclitaxel Export Destination, 2019
Figure 21. The Source of Imports of China Paclitaxel, 2019
Figure 22. PEST Analysis for China Paclitaxel Market in 2020
Figure 23. Paclitaxel Market Opportunities & Trends in China
Figure 24. Paclitaxel Market Drivers in China
Figure 25. Paclitaxel Market Restraints in China
Figure 26. Paclitaxel Industry Value Chain
Figure 1. Paclitaxel Segment by Type
Figure 2. Paclitaxel Segment by Application
Figure 3. Dangeguojia Paclitaxel Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Paclitaxel Market Size in China, (US$, Mn) & (Kg): 2020 VS 2026
Figure 6. China Paclitaxel Revenue, 2015-2026 (US$, Mn)
Figure 7. Paclitaxel Sales in China: 2015-2026 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Paclitaxel Revenue in 2019
Figure 9. By Type - China Paclitaxel Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - China Paclitaxel Market Share, 2015-2020
Figure 11. By Type - China Paclitaxel Market Share, 2020-2026
Figure 12. By Type - China Paclitaxel Price (USD/Kg), 2015-2026
Figure 13. By Application - Paclitaxel Revenue in China (US$, Mn), 2020 & 2026
Figure 14. By Application - China Paclitaxel Market Share, 2015-2020
Figure 15. By Application - China Paclitaxel Market Share, 2020-2026
Figure 16. By Application -China Paclitaxel Price (USD/Kg), 2015-2026
Figure 17. China Paclitaxel Production Capacity (Kg), 2015-2026
Figure 18. China Paclitaxel Actual Output (Kg), 2015-2026
Figure 19. China Paclitaxel Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of China Paclitaxel Export Destination, 2019
Figure 21. The Source of Imports of China Paclitaxel, 2019
Figure 22. PEST Analysis for China Paclitaxel Market in 2020
Figure 23. Paclitaxel Market Opportunities & Trends in China
Figure 24. Paclitaxel Market Drivers in China
Figure 25. Paclitaxel Market Restraints in China
Figure 26. Paclitaxel Industry Value Chain
